Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - CASH & EQUIVALENTS
Cash & Equivalents IBRX - ImmunityBio, Inc.
265 M
LAST VALUE
21.07%
2 YEAR CAGR
73.63%
5 YEAR CAGR
94.08%
10 YEAR CAGR